Dr. Xia Qiang

What they personally lead.

Training and recognition

Leads what has become one of the world's largest pediatric living-donor liver transplant programs at Renji Hospital, with over 3,000 pediatric liver transplants performed since the program's launch in 2006; the Renji center has consistently reported one-year graft survival rates above 90% for pediatric biliary atresia recipients, comparable to top international centers; recipient of the National Science and Technology Progress Award (Second Prize) for innovations in pediatric liver transplantation; published in Lancet, American Journal of Transplantation, and Liver Transplantation; serves on the Council of the International Liver Transplantation Society and as a leading figure in the Chinese Medical Association's transplant branch

What to expect

For pediatric patients with biliary atresia, metabolic liver disease, or other end-stage liver conditions requiring living-donor transplant from a parent or relative, Dr. Xia's program is one of the most experienced in the world. Renji Hospital evaluates international pediatric candidates through its transplant office; bring complete pediatric hepatology workup including bilirubin trends, PELD score, abdominal imaging, and donor evaluation if a parent is being considered. Wait times depend heavily on donor availability and recipient acuity.

Check the public record

Look up publications, citations, and academic profile on independent platforms before reaching out.

Results are automated searches and may include other individuals with similar names.